KLOW
-
Free shipping on orders $200+ (after discounts, before taxes).Flat rate shipping $15 on orders under $200.Estimated delivery time: 2–5 Business Days *Tracking provided once shipped.
KLOW Peptide Blend
KLOW is an 80mg multi-peptide research blend containing KPV, BPC-157, TB-500, and GHK-Cu. It is formulated for laboratory models examining inflammatory signaling, cellular migration, angiogenic pathways, extracellular-matrix activity, and tissue-repair mechanisms.
Each component is studied through a distinct biological pathway. KPV is investigated in inflammatory-response models, BPC-157 in cellular repair and vascular-signaling research, TB-500 in thymosin-related actin and endothelial pathways, and GHK-Cu in collagen, fibroblast, and extracellular-matrix studies.
80mg total blend. ≥99% component purity. Third-party tested. Lyophilized powder. Sterile vial integrity.
Blend Composition
Key Research Areas
- Inflammatory signaling research involving cytokine activity and cellular-response pathways
- Cell migration and repair models involving fibroblasts, endothelial cells, and connective tissue
- Angiogenic pathway research involving vascular signaling and endothelial activity
- Extracellular-matrix studies involving collagen, glycosaminoglycans, and tissue remodeling
- Actin and cytoskeletal research involving thymosin-related cellular-migration pathways
- Multi-pathway interaction models examining complementary cellular-signaling mechanisms
Mechanisms of Interest
KPV is the C-terminal tripeptide sequence of alpha-melanocyte-stimulating hormone. It is studied in laboratory models involving inflammatory mediators, cytokine activity, intestinal-barrier signaling, and cellular immune-response pathways.
BPC-157 is a synthetic pentadecapeptide examined primarily in preclinical models involving endothelial-cell migration, angiogenic signaling, fibroblast activity, nitric-oxide pathways, and connective-tissue response.
TB-500 is a thymosin-beta-4-related research peptide investigated for its relationship to actin regulation, cytoskeletal organization, endothelial-cell activity, cellular migration, and vascular-remodeling pathways.
GHK-Cu is a copper-binding tripeptide complex studied for its relationship to fibroblast signaling, collagen expression, glycosaminoglycan production, matrix-metalloproteinase activity, and extracellular-matrix remodeling.
Why Researchers Study KLOW
KLOW combines four independently studied compounds within one laboratory formulation. The blend supports research designs examining how inflammatory signaling, endothelial activity, cellular migration, cytoskeletal regulation, and extracellular-matrix pathways may be evaluated within the same experimental model.
The higher concentration of GHK-Cu makes extracellular-matrix and copper-peptide research a central focus of the formulation, while KPV, BPC-157, and TB-500 provide additional research targets involving inflammatory-response, vascular-signaling, and cellular-migration pathways.
This product is intended strictly for laboratory and research purposes. Not for human consumption, medical use, diagnostic use, or therapeutic use.

